Keywords
Systemic lupus erythematosus, infliximab, Crohn's disease
Abstract
The coexistence of systemic lupus erythematosus (SLE) and Crohn’s disease (CD) is very rare. The usual sequence of occurrence is CD followed by SLE, where CD treatment with anti-tumour necrosis factor (anti-TNF) induces the latter. Here, we present a case of this rare combination but with sequence reversal. The patient was unresponsive to steroids and we achieved remission with infliximab.
References
Views: 703
HTML downloads: 397
PDF downloads: 357
Published:
2021-06-29
Issue:
2021: Vol 8 No 6
(view)